Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.’s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

WHAT'S NEW

  • RFK Jr.'s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Feb 9 2021

Full Issue

First Member Of Congress Dies From Covid

Republican Rep. Ron Wright of Texas was hospitalized after testing positive for COVID-19. Wright was also being treated for lung cancer.

Houston Chronicle: Texas Republican Ron Wright Is First Member Of Congress To Die From COVID-19

Texas Rep. Ron Wright, a 67-year-old Republican from Arlington, died Sunday from COVID-19, according to a statement from his congressional office. He is the first sitting member of Congress to die of the virus. Wright and his wife, Susan, had been admitted to Baylor Hospital in Dallas two weeks ago after testing positive. (Wallace, 2/8)

Fort Worth Star-Telegram: U.S. Rep. Ron Wright Of Texas Dies After Battle With COVID

He said in December 2019 on the House floor he was being treated with “an immunotherapy wonder-drug called Keytruda,” which was approved for his regimen in May 2017. He used the success of the drug to argue against government forcing pharmaceutical companies to offer cancer drugs at lower costs, saying it could kill the innovation required to make the drug. He told Star-Telegram columnist Bud Kennedy in a Jan. 25 text message from Baylor Hospital that he was also facing pneumonia that came with the COVID infection. He said in the text that he was “on the mend.” “We need to package this stuff and send it back to China,” Wright jested in the text. (Hartley, 2/8)

In August, Rep. Ron Wright wrote an opinion piece expressing his hope in Republicans' plans for the future —

Fort Worth Star-Telegram: GOP Economic Plan Would Boost American Families, Businesses 

As insurmountable as our current challenges seem, the history of American ingenuity and perseverance leave me confident that these trying times will soon be behind us. After all, Americans have been tested time and time again in ways we never thought possible, and we have always come out on the other side a stronger nation. (Ron Wright, 8/19)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF